Is Sputnik V coming into being for Covid-19?

–Shrestha Dutta, Amity University Kolkata

The premier batch of the ‘Gam-COVID-Vac’ [Sputnik V] immunization for the prevention of novel Coronavirus, created by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has finished the vital quality assessments in the labs of Roszdravnadzor. Russian Health Minister Mikhail Murashko had declared that immunization against COVID-19 among volunteers under stage 3 of clinical preliminaries will begin this week. Moscow Mayor hopes that a greater number of the Russian capital’s inhabitants would be immunized against COVID-19 inside a while.

Concurrently, the CEO of the Russian Direct Investment Fund (RDIF), on Monday affirmed that the clinical trial of the Sputnik V immunization will start this month in nations, including India. Russia had said that almost 20 nations, including the UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil, and India, have expressed their desire for acquiring the antibody following enlistment. The after-effects of the stage 1-2 clinical preliminaries, released in the medical journal The Lancet, indicated 100 percent of members developed antibodies to the SARS-CoV-2 infection with no genuine symptoms.